Agreement - January 10, 2018
AMRA collaborates with Human Longevity
The two companies have made a new agreement that will see AMRA’s body composition profiling added to HLI’s premier health assessment, the Health Nucleus experience. “This is an exciting day for AMRA, as we take a significant step forward in our journey to advance the cause of precision medicine and preventive care. We hope that […]
Agreement - December 21, 2017
Xbrane Biopharma signs new agreement
The company has signed a distribution agreement with BL&H for sales and marketing of Spherotide in South Korea. Xbrane will receive mid-single digit SEK million license fee for the exclusive rights to Spherotide in South Korea and Xbrane and BL&H will share the profits from sales. “We are convinced that BL&H, with its strong position […]
Agreement - December 18, 2017
DelSiTech and C-Tri in agreement
Finnish DelSiTech and Korean C-Tri have signed a partnership and collaboration agreement to develop long-acting controlled release formulations with significant commercial potential. The first C-Tri product being developed in this partnership is NHM-CT-007, a peptide drug for oncology. “This partnership with C-Tri is an exciting opportunity for DelSiTech. It follows an already successful and long-lasting […]
Agreement - December 11, 2017
ExpreS2ion initiates collaboration on in vitro diagnostic products
ExpreS2ion Biotech Holding has announced that the fully owned subsidiary ExpreS2ion Biotechnologies has entered a collaboration with the Germany based Institut Virion\Serion GmbH. Virion is granted access to evaluate a number of new in vitro diagnostic product candidates, as well as commercial rights to promote, sell and distribute protein antigens produced using ExpreS2. The financial […]
Agreement - December 8, 2017
Getinge in strategic partnership with Verb Surgical
In this partnership, Getinge and Verb Surgical aim to combine their strengths to offer what they promise to be a game-changing platform for the next generation of surgery. The Getinge & Verb solution of Surgery 4.0, or Digital Surgery, will include robotics, advanced visualization, advanced instrumentation, operating room integration, connectivity and data analytics/AI. “Today’s announcement […]
Agreement - November 24, 2017
Bonesupport in commercialization agreement
BONESUPPORT has signed a second distribution agreement for Italy with Citieffe Srl to strengthen its access to trauma and orthopaedic surgeons in this market. Citieffe is a trauma implant manufacturer based in Bologna. It is part of the Medistream Group, owned by ArchiMed an independent French Healthcare Investment Firm. Citieffe, which has a direct sales force in Italy […]
